酒石酸溴莫尼定抑制劑Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
| 產(chǎn)品名稱： | 酒石酸溴莫尼定 | ||
| 英文名： | Brimonidine Tartrate | ||
| CAS NO.： | 70359-46-5 | ||
| 分子式： | C15H16BrN5O6 | ||
| 分子量： | 442.221442222595 | ||
| 產(chǎn)品品牌： | targetmol | ||
| 產(chǎn)品規(guī)格： | 10mg | ||
